The Impact of GlowCaps Connect™ and Its Services on Hypertension Medication Adherence: A Randomized Controlled Trial

Participants will use the GlowCap system for 6 months.

Group 1

• The GlowCap bottle provided for subjects in this group will passively track medication adherence over the course of the study
• The pill cap will collect data, but will not provide any visual or auditory alerts
• An Ethernet Gateway connector will collect adherence data from the pill bottle cap via a local wireless network. This data will be sent out of subject's home through the internet.

Group 2

• Subjects in this group will be given daily visual, auditory, and phone call reminders to take their medication via the GlowCap system if they fail to take their hypertension medication at the scheduled dose time
• An Ethernet Gateway connector will collect adherence data from the pill bottle cap via a local wireless network. This data will be sent out of subject's home through the internet.
• Subjects will receive Weekly and Monthly Progress Reports by email and mail, respectively. Reports will include information about medication adherence and target goals. If a subject does not opt-out, Monthly Progress Reports will also be sent to the subject's primary care physician (PCP)
• If the subject chooses, a friend or family member will receive a Weekly Progress Report by email
• If the subject chooses, he/she will receive prompts (via automated telephone call twice a month) to refill his/her prescription
• Subjects demonstrating consistent low adherence to medication will receive additional support in the form of calls from Vitality reminding them to take the medication.